1. Home
  2. PAR vs CTMX Comparison

PAR vs CTMX Comparison

Compare PAR & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PAR Technology Corporation

PAR

PAR Technology Corporation

N/A

Current Price

$21.94

Market Cap

699.1M

Sector

Miscellaneous

ML Signal

N/A

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

N/A

Current Price

$1.98

Market Cap

716.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PAR
CTMX
Founded
1968
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
699.1M
716.9M
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
PAR
CTMX
Price
$21.94
$1.98
Analyst Decision
Buy
Strong Buy
Analyst Count
9
8
Target Price
★ $26.63
$12.38
AVG Volume (30 Days)
1.0M
★ 5.0M
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $455,547,000.00
$76,201,000.00
Revenue This Year
$17.26
N/A
Revenue Next Year
$8.27
$36.55
P/E Ratio
★ N/A
$22.58
Revenue Growth
★ 30.16
N/A
52 Week Low
$11.59
$1.90
52 Week High
$40.54
$8.21

Technical Indicators

Market Signals
Indicator
PAR
CTMX
Relative Strength Index (RSI) 75.56 38.53
Support Level $12.64 N/A
Resistance Level $22.48 $2.61
Average True Range (ATR) 1.04 0.19
MACD 0.38 -0.00
Stochastic Oscillator 90.80 21.15

Price Performance

Historical Comparison
PAR
CTMX

About PAR PAR Technology Corporation

PAR Technology Corp is a foodservice technology company providing omnichannel cloud-based software and hardware solutions to the restaurant industry in three restaurant categories - quick service, fast casual, and table service - and the retail industry, including convenience and fuel retailers (C-Stores). Its product and service offerings include point-of-sale, customer engagement and loyalty, digital ordering and delivery, operational intelligence, payment processing, hardware, and related technologies, solutions, and services. The company generates revenue from subscription service, Sale of Hardware products, and Professional Service.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: